Understanding Preimplantation Genetic Testing for Aneuploidy (PGTA)
PGT-A, or Preimplatation Genetic Testing for Aneuploidies, is a genetic test performed during your IVF cycle with the goal of improving your chance of getting pregnant and having a healthy baby. PGT-A works by looking at the amount of genetic material within IVF embryos. This genetic material is housed within structures called chromosomes. Chromosomes are very important for healthy growth and development. Embryos with the incorrect number of chromosomes typically do not result in a successful pregnancy or may lead to the birth of a child with a genetic condition. Embryos with the correct number of chromosomes have a better chance of leading to a successful pregnancy. PGT-A identifies embryos with the correct number of chromosomes, so we can select the embryo with the best chance of leading to IVF success. PGT-A can sometimes be referred to as PGS, or preimplantation genetic screening.
Faster time to pregnancy. Performing PGT-A will tell you the genetic profile of each one, allowing you to select the embryo with the correct number of chromosomes for transfer.
Reduced number of IVF cycles needed to achieve pregnancy.
Reduced risk of miscarriage
More confidence in transferring a single embryo, avoiding health risks associated with twin or triplets.
On Day 5 or Day 6 of embryo development Embryo biopsy is performed.
A few cells are carefully removed from the part of the embryo that will form the placenta.
Samples are sent to the genetic laboratory while your embryos are frozen and kept in storage at ReproMed.
Your results are reviewed by our clinical team and you can access genetic counselling if necessary.
Ready to begin your fertility journey
You might be actively looking to grow your family right now, or just want to have an assessment of your fertility with a view to the future.
